$40.57
-0.580 (-1.41%)
At Close: Jun 03, 2026
Nestl reports three-month sales for 2020, provides COVID-19 update
05:18am, Friday, 24'th Apr 2020
This press release is also available in Français (pdf) and Deutsch (pdf) Follow today's event live 14:00 CEST Investor call audio webcast Full details in Events.
AbbVie: Strong Growth Ahead
05:42pm, Thursday, 23'rd Apr 2020
The pending $63 billion acquisition of Allergan is expected to close by summer 2020. Management expects the acquisition to produce $2 billion in synergies. ABBV
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
02:20pm, Thursday, 23'rd Apr 2020
Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
Form 8.3 - Allergan plc
02:15pm, Thursday, 23'rd Apr 2020
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1.
Drugmakers’ financial fortunes during Covid-19 may hinge on their product mix
12:05pm, Thursday, 23'rd Apr 2020
Analyst reports over the past few weeks have looked into what effects the Covid-19 pandemic could have on drugmakers' sales, examining multiple factors. But virtual launches and telemedicine could mit
Csenge Advisory Group Has $257,000 Holdings in Allergan plc (NYSE:AGN)
10:44am, Thursday, 23'rd Apr 2020
Csenge Advisory Group lifted its holdings in shares of Allergan plc (NYSE:AGN) by 17.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commis
North America Skin Aesthetic Devices Market to 2027 - Regional Analysis and Forecasts by Product ; Treatment ; End User ; and Country
10:37pm, Wednesday, 22'nd Apr 2020
The skin aesthetic devices market in North America is expected to reach US$ 2,025. 88 million in 2019; it is projected to grow at a CAGR of 11. The growth of the North American skin aesthetic device
Global Artificial Tears Industry
08:40pm, Wednesday, 22'nd Apr 2020
Artificial Tears market worldwide is projected to grow by US$457.1 Million, driven by a compounded growth of 3.7%. Artificial Tears, one of the segments analyzed and sized in this study, displays the
Were Hedge Funds Right About Allergan plc (AGN)?
05:22pm, Wednesday, 22'nd Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
02:20pm, Wednesday, 22'nd Apr 2020
Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
Form 8.3 - Allergan plc
02:15pm, Wednesday, 22'nd Apr 2020
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MO
AbbVie Gets FDA Nod for Imbruvica+Rituxan in First-Line CLL
11:46am, Wednesday, 22'nd Apr 2020
AbbVie's (ABBV) regulatory application seeking label expansion of Imbruvica as a first-line treatment for chronic lymphocytic leukemia in combination with Roche's Rituxan gets approval from the FDA.
TherapeuticsMD Further Strengthens Board with Appointment of New Independent Director
10:50am, Wednesday, 22'nd Apr 2020
On behalf of the Board of Directors of TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, Chairman Tommy G. Thompson today announced the appointment of Karen L.
Sign In
Buy ACT